# Sangamo Therapeutics, Inc: Form 8-K, filed Sep 21, 2026

- Company: [Sangamo Therapeutics, Inc](/companies/sgmoq.md) (CIK 1001233)
- Form: 8-K
- Filed: 2026-09-21
- Accepted by EDGAR: Sep 21, 2026, 16:01 ET
- Period: 2026-09-17
- Accession: 0001193125-26-396644
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1001233/000119312526396644/d178611d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1001233/000119312526396644/

## Items reported

- Item 1.03: Bankruptcy or receivership
- Item 2.01: Completion of an acquisition or disposition
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1001233/000119312526396644/d178611d8k.htm

Filed Sep 21, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-396644. Last ingested by Listed: Oct 27, 2026, 16:02 ET. No prices; not investment advice.